Innovent Biologics, Inc. (IVBIY)
OTCMKTS · Delayed Price · Currency is USD
51.09
0.00 (0.00%)
At close: Sep 25, 2025
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of $20.53 billion as of September 29, 2025. Its market cap has increased by 128.49% in one year.
Market Cap
20.53B
Enterprise Value
19.66B
Revenue
1.59B
Ranking
n/a
PE Ratio
129.89
Stock Price
$51.09
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 2.36B to 20.53B, an increase of 768.42%. That is a compound annual growth rate of 36.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 20.53B | 165.97% |
| Dec 31, 2024 | 7.72B | -12.83% |
| Dec 29, 2023 | 8.85B | 34.32% |
| Dec 30, 2022 | 6.59B | -27.14% |
| Dec 31, 2021 | 9.05B | -39.06% |
| Dec 31, 2020 | 14.84B | 244.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 721.78M |
| Tian'an Technology Group | 718.73M |
| Elite Pharmaceuticals | 670.79M |
| Glass House Brands | 518.99M |
| Northwest Biotherapeutics | 378.29M |
| CytoDyn | 347.53M |
| American Oncology Network | 308.52M |
| Nika Pharmaceuticals | 301.74M |